当前位置: X-MOL 学术medRxiv. Genet. Genom. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Sardinian founder mutation in GP1BB that impacts thrombocytopenia.
medRxiv - Genetic and Genomic Medicine Pub Date : 2020-07-08 , DOI: 10.1101/2020.07.06.20143263
Fabio Busonero , Maristella Steri , Valeria Orrù , Gabriella Sole , Stefania Olla , Michele Marongiu , Carlo Sidore , Sandra Lai , Antonella Mulas , Andrea Maschio , Magdalena Zoledziewska , Matteo Floris , Mauro Pala , Paola Forabosco , Isadora Asunis , Maristella Pitzalis , Francesca Deidda , Marco Masala , Cristian Antonio Caria , Susanna Barella , Goncalo R. Abecasis , David Schlessinger , Serena Sanna , Edoardo Fiorillo , Francesco Cucca

To investigate the genetic regulation of platelet (PLT) levels we carried out a whole-genome association analysis in 6,528 Sardinians from the general population of the Lanusei valley. We found 6 variants significantly influencing PLT levels, including a novel rare missense mutation (p.Pro27Ser) in the GP1BB protein that is associated with PLT reduction (P=1.17x10-16). This mutation is rare in the SardiNIA population cohort (frequency of 0.45%), even rarer in the rest of the Sardinian island (frequency of 0.16%), and not reported elsewhere. Notably, GP1BB is involved in Bernard-Soulier syndrome (BSS), a rare autosomal recessive bleeding disorder caused by a defect in the platelet GPIb-IX-V protein complex. Consistently, the 57 identified individuals heterozygous for the p.P27S mutation showed mild thrombocytopenia, morphologically enlarged platelets (P=2.13x10-10), and reduced expression of two GPIb-IX-V-complex components: GPIbα (-26.51%, P=3.66x10-8) and GPIX (-24.69%, P=2.66x10-6). Molecular modeling infers a corresponding reduction in the stability of GP1BB. These observations predict that in homozygosity as well as in individuals carrying specific compound heterozygous configurations, this variant likely causes BSS.

中文翻译:

GP1BB中的撒丁岛创始人突变,影响血小板减少症。

为了研究血小板(PLT)水平的遗传调控,我们在Lanusei山谷总人口的6,528名撒丁岛人中进行了全基因组关联分析。我们发现了6种显着影响PLT水平的变体,包括GP1BB蛋白中与PLT减少相关的新型罕见错义突变(p.Pro27Ser)(P = 1.17x10-16)。此突变在SardiNIA人群队列中很少见(频率为0.45%),在撒丁岛其他地区(频率为0.16%)则更罕见,在其他地方也未见报道。值得注意的是,GP1BB与Bernard-Soulier综合征(BSS)有关,该综合征是一种罕见的常染色体隐性出血性疾病,由血小板GPIb-IX-V蛋白复合物的缺陷引起。一致地,已鉴定出的p.P27S突变杂合子的57个人显示出轻度血小板减少症,形态上扩大的血小板(P = 2.13x10-10),并减少了两种GPIb-IX-V复合成分的表达:GPIbα(-26.51%,P = 3.66x10-8)和GPIX(-24.69%,P = 2.66x10 -6)。分子模型推断GP1BB的稳定性相应降低。这些观察结果预测,在纯合性以及携带特定化合物杂合子构型的个体中,此变异可能导致BSS。
更新日期:2020-07-08
down
wechat
bug